By  Dr. Joseph Mercola

By authorizing COVID-19 vaccines for young children on the basis of shoddy data, public health officials proved they’re in the business of protecting pharma’s profits, not people — and once enough people realize it, the entire childhood vaccine program will be finished.

• In late June, the United States became the first country in the world to grant Emergency Use Authorization (EUA) for Pfizer’s and Moderna’s COVID jabs for toddlers as young as 6 months. The U.S. Food and Drug Administration (FDA) issued the EUA on June 17, and the very next day, the Centers for Disease Control and Prevention (CDC) recommended all toddlers get the shot as soon as possible.
• The pediatric EUA was based on extremely weak evidence — and that’s after the FDA lowered its efficacy requirements for the pediatric population, even though they have the lowest risk of COVID and therefore have the least need for the shots.
• With this recommendation, the FDA and CDC have evaporated any last vestiges of trust they may have held onto. The reason they authorized COVID jabs for toddlers is because the drug industry needs this age group to be included under the EUA for legal indemnity purposes.
• Once the emergency is over, the next phase of liability shielding requires that the shots receive approval from the CDC’s Advisory Committee on Immunization Practices. Once the COVID jab is on the childhood vaccination schedule, the vaccine makers are permanently shielded from liability for injuries and deaths that occur in any age group, including adults.
• The FDA and CDC have sold out America’s children. Once enough people realize what they’ve done, they and the entire childhood vaccine program will be finished, as no one will trust any of the vaccines on the schedule. Already, only 44% of Americans believe what the CDC says.

[…]

It’s one thing to show regulatory flexibility during an emergency. But for children, COVID isn’t an emergency. The FDA bent its standards to an unusual degree and brushed aside troubling evidence that warrants more investigation.”

COVID is inconsequential for young children

Finley points out that only 209 children between the ages of 6 months and 4 years have died from COVID, per CDC data. She uses the word “from,” but the evidence suggests most children die “with” COVID and from other serious health conditions such as cancer.

That said, Finley does note that the two children in Pfizer’s pediatric trial who developed the most serious infections “also tested positive for other viruses,” so “it’s possible that many hospitalizations attributed to COVID this winter were actually instigated or exacerbated by other viruses.”

Another telling statistic is that the number of toddlers hospitalized with COVID between October 2020 and September 2021 was about half the total number of toddlers hospitalized with influenza the previous winter.

[…]

Shots don’t work well in young children

. . . while the shots initially seemed to offer robust protection for adults, the same cannot be said for children. The Moderna shot was only 51% effective against symptomatic Omicron infection in 6-month-olds to 2-year-olds, and a mere 37% effective in 2- to 5-year-olds.

[…]

“More troubling, vaccinated toddlers in Pfizer’s trial were more likely to get severely ill with COVID than those who received a placebo. Pfizer claimed most severe cases weren’t ‘clinically significant,’ whatever that means, but this was all the more reason that the FDA should have required a longer follow-up before authorizing the vaccine.

“Also worrisome: Most kids who developed multiple infections during the trial were vaccinated. This warranted more investigation since experimental vaccines for other diseases sometimes increase susceptibility to infection.

“Scientists are also discovering that triple-vaccinated adults who were previously infected with the Wuhan variant have a weaker immune response to Omicron, leaving them more susceptible to reinfection.

“This phenomenon, called ‘immunological imprinting,’ could explain why children who received three Pfizer shots were more likely to get reinfected.”

CDC and FDA are recklessly throwing caution to the wind

[…]

This ongoing “training” that the immune system undergoes during the first few years of a child’s life is what allows them to develop a well-functioning immune system over time. Immunological imprinting could throw a huge wrench in the works, making children less able to combat infections.

Young children are exceptionally “hardy” and can bounce back from most infections.

However, that’s provided something hasn’t been done that prevents their immune system from functioning normally. Of course, we also know the shots are associated with even more serious effects, including heart inflammation, neurological disorders and cancer.

[…]

CDC is breaking trust in childhood vaccination

Leslie Bienen and Tracy Beth Høeg addressed the CDC’s self-imposed self-destruction in a July 5 Tablet magazine article, in which they noted that “With its unscientific push to vaccinate all infants and toddlers against COVID, the agency will harm vaccine uptake for more significant diseases.”

The duo cites polling data showing a majority of parents are skeptical of the CDC’s recommendation to jab their young children. Only 18% of respondents said they were eager to get their babies and toddlers inoculated, while 38% said they would wait and see if there are side effects; 27% said they would “definitely not” get their child jabbed.

[…]

Indeed, one of the few silver linings of COVID is that people are starting to wake up in droves, realizing the entire childhood vaccination program has been misrepresented, just like the COVID shots are being misrepresented.

For example, I recently interviewed Dr. Robert Malone, who stated:

“I’m now completely in the same camp as Bobby Kennedy, in that I believe the entire vaccine enterprise needs to be revisited, and it’s unequivocal.

“We do not have the data to support the safety and efficacy of the current pediatric vaccine schedule, and all of the components of the pediatric vaccine schedule need to be reassessed for risk-benefit ratio. Both as individual products and as combined products.”

[…]

Why did two-thirds of toddlers drop out of Pfizer’s trial?

[…]

In “How Vaccine Trials Routinely Rig the Results,” I also discussed other red flags, such as the fact that 3,000 of the 4,526 children (aged 6 months through 4 years) enrolled in Pfizer’s pediatric COVID trial were excluded, without explanation.

Oftentimes, trial participants drop out or are excluded due to severe side effects. Here, we don’t know why two-thirds of the participants were eliminated, and according to Dr. Clare Craig, a diagnostic pathologist, a 66% dropout rate should have been sufficient to deem the trial null and void (see video below).

[…]

It’s all about securing indemnification

As explained by Robert F. Kennedy, Jr., in the short video clip above, they need this last remaining age group to be included under the EUA, because once the emergency is finally declared “over,” the next phase of liability shielding requires that the shots receive approval by the CDC’s Advisory Committee on Immunization Practices.

[…]

Via https://childrenshealthdefense.org/defender/fda-cdc-american-children-childhood-vaccine-program-cola/